National Institutes of Health
Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure - Clinical Research Sites (U24 Clinical Trial Not Allowed)
Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure - Clinical Research Sites (U24 Clinical Trial Not Allowed) is a funding opportunity from National Institutes of Health, closing November 1, 2027.
Overview
The National Institute of Neurological Disorders and Stroke (NINDS), at the National Institutes of Health (NIH) seek to continue support for the Infrastructure for the Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT). NeuroNEXT conducts clinical trials and biomarker validation studies for…